Accor S.A. Inh. sell BiotechBee
Start price
22.09.22
/
60%
€21.98
Target price
31.12.24
€16.00
Performance (%)
8.28%
End price
02.01.23
€23.80
Summary
This prediction ended on 02.01.23 with a price of €23.80. With a performance of 8.28%, the SELL prediction by BiotechBee for Accor S.A. Inh. was trending in the wrong direction BiotechBee has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Accor S.A. Inh. | -1.906% | -1.906% | -0.309% | 60.551% |
| iShares Core DAX® | 0,39 % | 0,15 % | 10,96 % | 58,44 % |
| iShares Nasdaq 100 | 1,31 % | -2,55 % | -0,61 % | 84,24 % |
| iShares Nikkei 225® | -0,46 % | 6,89 % | 26,75 % | 63,40 % |
| iShares S&P 500 | 1,31 % | -1,16 % | -0,04 % | 58,22 % |
According to BiotechBee what are the pros and cons of Accor S.A. Inh. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by BiotechBee for this prediction
In the thread Accor S.A. Inh. diskutieren
Sell mit Kursziel 16,0